drugset / Trial / NCT01969227

The Effects of Ketamine on Respiratory Stimulation and Transpulmonary Pressures

NCT01969227 ↗

NaSingle-groupOpen-labelTreatment

Summary

Impairment of airway patency is a common cause of extubation failure and opioids and hypnotics can adversely affect airway patency. Ketamine, a noncompetitive antagonist of N-methyl-D-aspartate (NMDA), unlike other anesthetics activates respiratory effort and promotes bronchodilation. At subanesthetic plasma concentration, ketamine reduces both opioid and propofol requirements. The purpose of this pharmaco-physiological interaction trial is to evaluate the effects of ketamine on breathing and electroencephalography in mechanically ventilated patients.

Timeline

Start
2014-01
Primary completion
2022-12
Completion
2022-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 10 ug/kg —